Form 4 for STOK Stoke Therapeutics, Inc.
Accepted 2024-02-15 00:00:00 ET · period of report 2024-02-13 · accession 0001415889-24-003897 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-15 | 2024-02-13 | STOK | TZIANABOS ARTHUR | Dir | M - OptEx | $2.19 | +31.7K | 31.7K | New | +$69.5K |
| D | 2024-02-15 | 2024-02-13 | STOK | TZIANABOS ARTHUR | Dir | M - OptEx | $0.00 | -31.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-13 | M | A | 31,739 | $2.19 | 31,739 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-02-13 | M | D | 31,739 | $0.00 | 0 | D | $2.19 · — to 2028-12-12 | 31,739 Common Stock | (F1) This fully-vested option award vested as to 1/48th of the total award on October 4, 2018 with 1/48th of the total award vesting monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date. |